Paandu Kudineer For Paandu Noi(Iron Deficiency Anaemia)

Phase II Non Randomized Clinical Study On Paandu Noi(Iron Deficiency Anaemia) With The Evaluation Of Siddha Trial Drug Paandu Kudineer In Children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034536

Enrollment

Registered

2021-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Paandu kudineer: Paandu kudineer 15-30 ml bd after food for 21 days Intervention2: Paandu kudineer : 15-30 ml bd after food for 21 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Pallor of Skin, Mucous membrane, Nail bed Lower Palpebral Conjuctiva Constipation Tiredness Generalised Muscular Weakness Poor School Performance and Lack of Concentration.

Exclusion criteria

Exclusion criteria: Hb less than 7grams known H/O Hemolytic Anaemia Hereditary bleeding disorder i.e(Hemophilia) Patient with chronic disease i.e(Thalassemia, Chronic malnutrition)

Design outcomes

Primary

Measure	Time frame
Reduction in Clinical Symptoms before and after treatmentTimepoint: 21 days	—

Secondary

Measure	Time frame
Comparing safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Vijayalakshmi V

Government Siddha Medical College, Arumbakkam, Chennai-106.

drvranimd@yahoo.com6369113461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026